PVT1 and melanoma: Further analysis with 51 melanoma patients and 47 non-melanoma patients revealed the ability to discriminate patients from controls based on serum PVT1 levels with a sensitivity of 94.12%, depicting the potential diagnostic value of PVT1 in malignant melanoma.